#Molecular Diagnostics

Lead report

Co-Diagnostics India TB Test Commercialization Q3 2026, CoSara SPAC Options Under Review

Co-Diagnostics announces India tuberculosis test product expected to commercialize in Q3 2026 while evaluating SPAC options for CoSara business. Analysis of market strategy outlook and investment considerations.